Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer
Clinical trial NCT01242631 · COMPLETED
Trial details
- NCT number
- NCT01242631
- Sponsor
- Hannover Medical School
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2014-03-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.